Konstantinos Stavroulakis, Angeliki Argyriou, Mike Watts, Joji J Varghese, Bailey A Estes, Giovanni Torsello, Theodosios Bisdas, Bella Huasen
Journal: The Journal of cardiovascular surgery 2019;60(5):572-581
PMID: 31241269
Despite the continuous evolution of endovascular therapy, severe calcification remains a major issue for the minimally invasive treatment of superficial femoral artery (SFA) disease. The presence of calcium might negatively affect both the crossing of peripheral lesions and outcomes of all available treatment modalities and is therefore associated with unfavorable acute and long-term results. This manuscript summarizes the challenges raised from severe calcified atherosclerotic lesions and presents the outcomes of the various endovascular modalities in the treatment of calcified SFA disease.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.